Regencell Bioscience Holdings Limited
RGC•NASDAQ•Healthcare•Drug Manufacturers - Specialty & Generic

About Regencell Bioscience Holdings

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Websitewww.regencellbioscience.com
Phone852 2155 0823
Address
Chinachem Leighton Plaza, 9th Floor Causeway Bay Hong Kong

Corporate Identifiers

CIK0001829667
CUSIPG7487R100
ISINKYG7487R1002
SIC2833

Leadership Team & Key Executives

Yat-Gai Au
Founder, Chairman and Chief Executive Officer
Michelle Chan
Financial Controller, Chief Financial Officer and Principal Financial Officer
Wai Hong Chung
Chief Operating Officer, Chief Strategy Officer and Director
Antonia Assang
Senior Vice President of Project Management
Yat-Pui Au
Chief Business Officer